Mode
Text Size
Log in / Sign up

Meta-analysis finds exercise training reduces intrahepatic lipids and improves metabolic markers in NAFLDWhich Workout Melts Liver Fat Fastest? New Rankings Are In

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider exercise training as a component of lifestyle therapy for reducing liver fat and improving metabolic markers in NAFLD.

This systematic review and meta-analysis examined the effects of exercise training on intrahepatic lipid content and metabolic markers in adults with nonalcoholic fatty liver disease (NAFLD). The analysis pooled data from 1,880 participants across multiple studies. The population specifically comprised adults with and without NAFLD, though the exact clinical characteristics and baseline severity of liver disease were not detailed in the provided data. The setting of the included studies was not reported.

The intervention evaluated was exercise training, which encompassed several modalities: high-intensity interval training (HIIT), aerobic training, combined aerobic and resistance training, and resistance training. The comparator groups were either nonexercise control groups or groups receiving other types of exercise training, allowing for assessment of exercise versus no exercise and comparisons between different exercise regimens. Specific details on exercise dosing, such as frequency, intensity, duration, and total program length, were not provided in the input data.

The primary outcome was intrahepatic lipid content. Exercise training was significantly more effective than nonexercise controls at reducing intrahepatic lipids, with a standardized mean difference (SMD) of -0.33 (p = 0.001). This represents a small-to-moderate effect size favoring the exercise interventions.

Key secondary outcomes also showed significant benefits. For glucose homeostasis markers, exercise training led to greater reductions in fasting blood glucose (weighted mean difference [WMD]: -2.27 mg/dL, p = 0.007), fasting insulin (SMD: -0.16, p = 0.02), and glycated hemoglobin (SMD: -0.13, p = 0.03) compared to nonexercise groups. Regarding liver function enzymes, exercise was associated with greater reductions in alanine aminotransferase (ALT; WMD: -3.72 U/L, p = 0.001) and aspartate aminotransferase (AST; WMD: -3.51 U/L, p = 0.02). However, the analysis found no significant differences between groups for the outcome of insulin resistance.

Safety and tolerability findings were not reported in the provided data. There is no information on adverse events, serious adverse events, discontinuation rates, or general tolerability of the various exercise interventions across the pooled studies.

These results align with and consolidate evidence from prior smaller trials and reviews suggesting that physical activity is beneficial for reducing liver fat and improving metabolic parameters in NAFLD. The finding of no significant effect on insulin resistance, however, contrasts with some individual studies and highlights the complexity of measuring this outcome and the variable responses to exercise.

Key methodological limitations stem from the nature of meta-analyses. The quality and risk of bias depend entirely on the constituent studies, which were not described. Potential biases include publication bias, heterogeneity in exercise protocols and intensities across studies, and variability in how outcomes like intrahepatic lipids were measured (e.g., MRI-PDFF, MRS, biopsy). The lack of reported safety data is a significant limitation for clinical application. Furthermore, the analysis could not determine which specific exercise modality (HIIT, aerobic, resistance, or combined) was most effective, as comparisons between exercise types were not detailed.

The clinical implication is that this meta-analysis provides pooled, quantitative evidence supporting the integration of structured exercise training into the lifestyle management plan for patients with NAFLD. It demonstrates benefits beyond liver fat reduction to include improvements in glycemic control and liver enzymes. For practice, this reinforces current guideline recommendations promoting physical activity. However, clinicians should note that the evidence does not point to a single superior exercise type and that the absolute reductions in liver enzymes, while statistically significant, are modest.

Several important questions remain unanswered. The optimal exercise prescription—including the most effective type, required intensity, frequency, and duration—for NAFLD management is still unclear. The long-term sustainability of these benefits and their impact on hard clinical endpoints like progression to steatohepatitis (NASH), cirrhosis, or liver-related mortality are unknown. The safety profile of different exercise regimens in a NAFLD population, particularly those with comorbidities, was not reported and requires investigation. Finally, how exercise compares or synergizes with pharmacological therapies for NAFLD is a critical area for future research.

The silent problem sitting in your liver

Your liver does a lot.

It filters toxins, balances your blood sugar, and helps digest food. But in many adults — often without any warning — it starts to store fat inside its own cells.

That condition is called nonalcoholic fatty liver disease, or NAFLD. And the scary part is most people don't know they have it.

NAFLD affects roughly 1 in 4 adults worldwide.

It often travels with type 2 diabetes, high blood pressure, and obesity. Left alone, it can slowly scar the liver and raise the risk of serious problems down the line.

There are few approved medicines for it. Lifestyle change is still the frontline treatment. That's why the exercise question is so important — and why comparing the options really matters.

The old vs the new

For years, doctors told patients the same thing: lose weight and move more.

But here's the twist. "Move more" is vague. Does any workout work? Is lifting weights as good as jogging? Does high-intensity interval training (HIIT) actually beat longer, slower sessions?

This new review used network meta-analysis — a method that can rank different exercises against each other using indirect comparisons — to answer that exact question.

How it works, in plain terms

Think of liver fat (intrahepatic lipid = fat inside liver cells) as grease in a frying pan.

Gentle cooking can burn some off. A hotter flame burns it faster. The right exercise works like turning up the heat — forcing the liver to dip into its fat stores for fuel.

Exercise also makes muscle and liver cells more sensitive to insulin, the hormone that controls blood sugar. That's why the benefits reach beyond the liver itself.

The researchers searched four major databases from inception through August 2025.

They looked for randomized trials that compared exercise training against no exercise or against another type of exercise. Adults with and without NAFLD were included.

Thirty-eight studies met their bar. Together, those trials covered 1,880 participants.

Exercise won across the board.

Compared to not exercising, training lowered liver fat in a meaningful, statistically confirmed way. The effect held up across ages, body sizes, sexes, fatty liver severity, and whether people lost weight during the program.

That last point is worth repeating. Even without big weight loss, exercise trimmed liver fat.

Exercise lowered liver fat even when the scale didn't move much.

When the team ranked the four common exercise types:

  • High-intensity interval training (HIIT) — top rank
  • Aerobic training (steady cardio like cycling or jogging) — second
  • Combined aerobic plus resistance (weights) — third
  • Resistance training alone — last

On the metabolic side, exercise also lowered fasting blood sugar by a small but meaningful amount, dropped fasting insulin, nudged down hemoglobin A1c (a three-month blood sugar average), and reduced two liver enzymes (ALT and AST) that rise when the liver is inflamed.

Here's where it gets interesting

Insulin resistance — the deeper glucose problem behind type 2 diabetes — did not improve significantly overall.

That's a reminder that exercise helps many things at once but doesn't fix everything. Combining exercise with diet change may still be needed to move the hardest markers.

Liver specialists have been leaning toward HIIT-friendly recommendations for several years.

This review strengthens that direction without dismissing other options. Aerobic work ranked a close second. And for someone who can't sprint or push hard — due to age, joints, or heart issues — steady aerobic exercise is a very strong choice.

If you have NAFLD or prediabetes, the single most useful takeaway is: the best workout is the one you'll actually do consistently.

If you enjoy and tolerate hard efforts, HIIT (short bursts of intense activity with rests) may pack the biggest liver-fat punch per minute. Talk to your doctor first, especially if you have heart disease, are new to exercise, or take medications.

If HIIT isn't your style, steady brisk walking, cycling, or swimming still delivers major benefits. Adding some resistance training helps overall health too, even if it ranked last for liver fat alone.

A network meta-analysis is only as good as its inputs.

The 38 studies used different programs, different session lengths, and different ways of measuring liver fat. Some trials were short. Diet was handled differently across studies. "HIIT" itself can mean different things in different protocols.

These factors can blur exact rankings. The overall direction — exercise helps the liver — is solid. The precise winner by a nose is less certain.

Future trials can help nail down the ideal exercise prescription: how intense, how often, how long, and for whom.

Researchers are also exploring how exercise combines with newer metabolic drugs and with diet patterns like Mediterranean eating. For now, the message is empowering and practical.

Study Details

Study typeMeta analysis
Sample sizen = 1,880
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
OBJECTIVES: This study investigated the effects of different exercise interventions on intrahepatic lipid content and markers of glucose homeostasis and liver function in adults with and without nonalcoholic fatty liver disease (NAFLD). METHODS: A comprehensive search was conducted in PubMed, Scopus, Web of Science, and EMBASE using three primary keywords including "exercise training," "liver fat," and "randomization" from inception to August 2025. Eligible studies were those that compared exercise training with either nonexercise groups or other types of exercise training. RESULTS: Thirty-eight studies comprising 1880 participants were included. Exercise training was more effective for reducing intrahepatic lipids [SMD: -0.33, p = 0.001], confirmed through subgroup analyses based on age, health status, body mass index, intervention duration, specific health status, frequency of weekly exercise sessions, biological sex, steatosis classification, and weight change%. Based on the p-score rankings, the intervention that was likely to be the most effective for lowering intrahepatic lipids was high-intensity interval training (p = 0.95), followed by aerobic training (p = 0.77), combined aerobic and resistance training (p = 0.52), and resistance training (p = 0.10). Secondarily, exercise training reduced fasting blood glucose [WMD: -2.27 mg/dL, p = 0.007], fasting insulin [SMD: -0.16, p = 0.02], glycated hemoglobin [SMD: -0.13, p = 0.03], and liver function enzymes including alanine aminotransferase (ALT) [WMD: -3.72 U/L, p = 0.001] and aspartate aminotransferase (AST) [WMD: -3.51 U/L, p = 0.02] significantly more than nonexercise groups. However, there were no significant differences in insulin resistance. CONCLUSIONS: These results provide evidence of the effects of different exercise interventions as part of a healthy lifestyle for reducing intrahepatic lipids and markers of glucose dysmetabolism. PROSPERO Registration: CRD42025639421.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.